Navigating 11 Analyst Ratings For Bicycle Therapeutics
Navigating 11 Analyst Ratings For Bicycle Therapeutics
導航bicycle therapeutics的11個分析師評級
Analysts' ratings for Bicycle Therapeutics (NASDAQ:BCYC) over the last quarter vary from bullish to bearish, as provided by 11 analysts.
分析師對Bicycle Therapeutics(納斯達克:BCYC)在上個季度的評級從看好到看淡不等,共有11位分析師提供了這些評級。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級,提供了對過去30天情緒變化的洞察,並與前幾個月進行了比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $41.82, a high estimate of $55.00, and a low estimate of $28.00. Observing a downward trend, the current average is 2.74% lower than the prior average price target of $43.00.
分析師的12個月價格目標的洞察被揭示,顯示平均目標爲41.82美元,最高估計爲55.00美元,最低估計爲28.00美元。觀察到一個 downward trend,目前的平均值比之前的平均價格目標43.00美元低2.74%。
Diving into Analyst Ratings: An In-Depth Exploration
深入探討分析師評級:分析師評級的深度探討
The standing of Bicycle Therapeutics among financial experts is...
對Bicycle ...
登入免費觀看全文
登入/註冊